Chinese medicinal preparation for treating rheumatic heart valve disease

Abstract

The invention discloses a Chinese medicinal preparation for treating a rheumatic heart valve disease, which is prepared from the following raw materials in part by weight: 35 to 80 parts of umbrella sedge, 30 to 75 parts of megaphyll sarcococca ruscifolia, 30 to 75 parts of centranthera grandiflora, 25 to 65 parts of heterophylly falsestarwort root, 25 to 65 parts of danshen root, 25 to 65 parts of astragalus, 15 to 55 parts of safflower, 20 to 60 parts of Chinese angelica and 15 to 55 parts of peach seed. The Chinese medicinal preparation for treating the rheumatic heart valve disease has the effects of freeing stenosion, repairing valves, freeing channels and quickening network vessels, supplementing both vital energy and blood, and dispelling stasis and dissipating binds to thoroughly cure the rheumatic heart valve disease. Clinical application shows that the Chinese medicinal preparation has the effective rate of 100 percent when taken in 30 days for the general rheumatic heart valve disease, has the effective rate of 93 percent for invisible and early seizure, and has the effective rate of 100 percent and the cure rate of 95 percent when taken in 60 days.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a traditional Chinese medicine preparation for treating rheumatic heart valve disease. Background technique [0002] Rheumatic valvular heart disease is the "heart valve disease" left over from rheumatic carditis. It is still one of the common diseases in my country at present, and it is more common in children and adolescents. The main manifestations are (1) mitral valve stenosis, mild mitral valve stenosis in the early stage, most of which have no obvious symptoms, and when left heart failure occurs, breathing Difficulty, exertional dyspnea, paroxysmal nocturnal dyspnea, acute pulmonary edema. In right heart failure, distended jugular veins, hepatomegaly with tenderness, pitting edema of the lower extremities may occur, and dehydration and cardiogenic cirrhosis may occur in the late stage. (2) Mitral valve insufficiency, mostly rheumatic, about 50% of patients with...

AI Technical Summary

Problems solved by technology

[0003] At present, there is no special drug for the treatment of rheumatic valvular heart disease. The general medical treatment principles of western medicine are mainly to maintain and improve the compensatory function of the heart, limit physical activity, prevent streptococcal infection, and prevent rheumatic recurrence, such as cardiac insufficiency or atrial fibrillation, etc. Complications, 1.2 million units of long-acting penicillin is injected every winter and spring for prevention. There is no drug to treat this disease, so it can only be prevented passively